Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bioceres Crop Solutions (BIOX) Non Operating Income (2016 - 2026)

Bioceres Crop Solutions' Non Operating Income history spans 5 years, with the latest figure at -$9.7 million for Q1 2026.

  • On a quarterly basis, Non Operating Income fell 73.21% to -$9.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$15.5 million, a 58.11% decrease, with the full-year FY2025 number at -$14.1 million, up 1.38% from a year prior.
  • Non Operating Income hit -$9.7 million in Q1 2026 for Bioceres Crop Solutions, down from -$5.6 million in the prior quarter.
  • Over the last five years, Non Operating Income for BIOX hit a ceiling of -$26000.0 in Q2 2022 and a floor of -$9.7 million in Q1 2026.
  • Historically, Non Operating Income has averaged -$5.1 million across 3 years, with a median of -$5.6 million in 2025.
  • Biggest five-year swings in Non Operating Income: soared 81.82% in 2022 and later plummeted 73.21% in 2026.
  • Tracing BIOX's Non Operating Income over 3 years: stood at -$26000.0 in 2022, then tumbled by 21438.46% to -$5.6 million in 2025, then tumbled by 73.21% to -$9.7 million in 2026.
  • Business Quant data shows Non Operating Income for BIOX at -$9.7 million in Q1 2026, -$5.6 million in Q1 2025, and -$26000.0 in Q2 2022.